Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-17

FDA Approved: ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE — Original Application (A2A Integrated Pharmaceuticals)

View source ↗

Summary

FDA approved a generic fixed-dose combination of isosorbide dinitrate and hydralazine hydrochloride for heart failure, manufactured by A2A Integrated Pharmaceut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Dinitrate and Hydralazine Hydrochloride (Isosorbide Dinitrate and Hydralazine Hydrochloride)

Snippet

ORIG AP for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE (ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE)